Bioptik Technology Incorporation (4161) Stock Overview

Bioptik Technology Incorporation researches, develops, produces, and sells medical devices and reagents in Taiwan and internationally. The company offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. It also provides skin care products and dietary supplements, as well as biodiesel products. The company was founded in 1999 and is headquartered in Zhunan, Taiwan.